Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
Jonathan D. Licht(University of Florida Health), Wilson H. Miller(Jewish General Hospital), Amy A. Scott(Mount Sinai Medical Center), André Goy(Hackensack University Medical Center), Alex Chen(Mount Sinai Medical Center), David R. Head(University of Southern California), Jean Louis Michaux(Mount Sinai Medical Center), Christine Chomienne(Inserm), A DeBlasio(Mount Sinai Medical Center), Yu Wu(Nanjing Normal University)
Cited by 351
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k